Modelling paper using data from prospective clinical trials highlights major impact of higher doses of primaquine and tafenoquine on P.vivax recurrences and #vivax transmission. Coverage, adherence and safety will be key elements in implementation.
www.thelancet.com/journals/lan...
Substantial reductions in prevalence as measured by PCR were predicted with primaquine
and tafenoquine regimens if these could be implemented with high coverage and adherence.
The benefits of preventi...
